Yang Zi Wan Bao Wang·2025-10-08 23:17Market Overview - The stock market experienced significant activity on the first trading day of October, with notable performances from various companies, including 蓝丰生化 (Bluefeng Biochemical) achieving a seven-day consecutive rise [1] - The total trading volume in the Shanghai and Shenzhen markets reached 2.18 trillion yuan, an increase of 20 billion yuan compared to the previous trading day [1] - Key sectors showing strong performance included non-ferrous metals and storage chips, while sectors such as liquor and large financials faced declines [1] Company Announcements - 复星医药 (Fosun Pharma) announced that its subsidiary received approval for clinical trials of a new drug for treating advanced solid tumors, with a total R&D investment of approximately 150,000 yuan expected by August 2025 [2] - 恒瑞医药 (Hengrui Medicine) received approval for clinical trials of its innovative anti-tumor drug HRS-2329, with a cumulative R&D investment of about 6.015 million yuan [2] External Market Influences - The US stock market saw the Nasdaq and S&P 500 indices reach new closing highs, with AMD shares rising over 11%, marking a 43% increase over three days, the best performance in nine years [3] - The Federal Reserve's probability of a 25 basis point rate cut in October is at 94.6%, indicating a strong expectation for a reduction in interest rates [4]